Free Trial
NASDAQ:CRIS

Curis (CRIS) Stock Price, News & Analysis

Curis logo
$1.84 +0.09 (+5.14%)
Closing price 07/3/2025 01:59 PM Eastern
Extended Trading
$1.78 -0.06 (-2.99%)
As of 07/3/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Curis Stock (NASDAQ:CRIS)

Key Stats

Today's Range
$1.70
$1.98
50-Day Range
$1.75
$2.80
52-Week Range
$1.02
$8.29
Volume
131,473 shs
Average Volume
80,098 shs
Market Capitalization
$19.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Buy

Company Overview

Curis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

CRIS MarketRank™: 

Curis scored higher than 58% of companies evaluated by MarketBeat, and ranked 435th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Curis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Curis has only been the subject of 1 research reports in the past 90 days.

  • Read more about Curis' stock forecast and price target.
  • Earnings Growth

    Earnings for Curis are expected to grow in the coming year, from ($7.12) to ($3.49) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Curis is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Curis is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Curis' valuation and earnings.
  • Percentage of Shares Shorted

    1.24% of the float of Curis has been sold short.
  • Short Interest Ratio / Days to Cover

    Curis has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Curis has recently decreased by 10.57%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Curis does not currently pay a dividend.

  • Dividend Growth

    Curis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.24% of the float of Curis has been sold short.
  • Short Interest Ratio / Days to Cover

    Curis has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Curis has recently decreased by 10.57%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Curis has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Curis this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for CRIS on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Curis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.45% of the stock of Curis is held by insiders.

  • Percentage Held by Institutions

    Only 29.97% of the stock of Curis is held by institutions.

  • Read more about Curis' insider trading history.
Receive CRIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curis and its competitors with MarketBeat's FREE daily newsletter.

CRIS Stock News Headlines

Curis Announces $7M Securities Purchase Agreement
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

CRIS Stock Analysis - Frequently Asked Questions

Curis' stock was trading at $3.06 at the start of the year. Since then, CRIS stock has decreased by 39.9% and is now trading at $1.84.

Curis, Inc. (NASDAQ:CRIS) issued its quarterly earnings data on Tuesday, May, 6th. The biotechnology company reported ($1.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.14) by $0.11. The biotechnology company earned $2.38 million during the quarter, compared to analyst estimates of $2.37 million.
Read the conference call transcript
.

Curis's stock reverse split before market open on Friday, September 29th 2023.The 1-20 reverse split was announced on Friday, September 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of CRIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Curis investors own include Micron Technology (MU), Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), NIO (NIO), Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
5/06/2025
Today
7/06/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CRIS
Employees
60
Year Founded
2000

Price Target and Rating

Average Stock Price Target
$17.00
High Stock Price Target
$17.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+823.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.39 million
Net Margins
-376.08%
Pretax Margin
-376.08%

Debt

Sales & Book Value

Annual Sales
$10.91 million
Price / Cash Flow
N/A
Book Value
($0.71) per share
Price / Book
-2.59

Miscellaneous

Free Float
9,892,000
Market Cap
$19.25 million
Optionable
No Data
Beta
3.60

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CRIS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners